An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study ID
- NCT02677961
- Status
- Recruiting
Conditions
- Bone Neoplasms
- Neoplasms, Connective and Soft Tissue
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Observation — OTHER
Study Details
Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.
Key Dates
- Start date
- Jul 1, 2015
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 1,500 participants (estimated)
Primary Outcome Measure
Overall Survival [ Time Frame: 5 Years ]
Central Contacts
- Erin Fetzer
- David A Liebner, MD(614) 293-2886
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University | Columbus | Ohio | 43210 | Erin Fetzer |
Find similar trials in Columbus, OH
By research site